American National Registered Investment Advisor’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$325K Hold
5,976
0.12% 210
2021
Q4
$329K Hold
5,976
0.11% 210
2021
Q3
$285K Hold
5,976
0.1% 214
2021
Q2
$297K Hold
5,976
0.11% 216
2021
Q1
$267K Hold
5,976
0.1% 218
2020
Q4
$275K Hold
5,976
0.11% 193
2020
Q3
$281K Hold
5,976
0.13% 171
2020
Q2
$305K Hold
5,976
0.15% 161
2020
Q1
$283K Hold
5,976
0.18% 153
2019
Q4
$351K Hold
5,976
0.17% 165
2019
Q3
$319K Buy
+5,976
New +$307K 0.18% 169

Other funds holding GSK

American National Registered Investment Advisor's GSK Position: Q1 2022 in Review

American National Registered Investment Advisor held its GSK (GSK) position steady in Q1 2022 at 5,976 shares worth $325K. The position accounts for 0.12% of the portfolio, ranked #210.

American National Registered Investment Advisor first reported a position in GSK in Q3 2019 and has held it in 11 quarters since. The position peaked at $351K in Q4 2019. 930 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • American National Registered Investment Advisor held 5,976 shares of GSK worth $325K as of Q1 2022.
  • American National Registered Investment Advisor left its GSK share count unchanged in Q1 2022.
  • GSK made up 0.12% of American National Registered Investment Advisor's portfolio in Q1 2022, its #210 holding.
  • American National Registered Investment Advisor first reported a position in GSK in Q3 2019 and has held it in 11 quarters since.
  • American National Registered Investment Advisor's GSK position peaked at $351K in Q4 2019.
  • 930 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on American National Registered Investment Advisor's 13F filing for Q1 2022, filed 13 May 2022.